|Bid||120.00 x 800|
|Ask||300.00 x 900|
|Day's Range||243.08 - 251.62|
|52 Week Range||137.21 - 327.32|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||94.49|
|Earnings Date||Oct 26, 2022 - Oct 31, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||266.56|
Subscribe to Yahoo Finance Plus to view Fair Value for RGEN
Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...
Yesterday, Catalent Inc (NYSE: CTLT) announced to acquire Metrics Contract Services for $475 million. Keybanc notes that the deal strengthens CTLT's oral delivery portfolio and targets rapidly growing biologic applications. Metrics produces highly active pharmaceutical ingredients that are very difficult to produce but very potent in small doses. "After recent acquisitions and capacity expansion on the cell and gene therapy front, this acquisition will continue to balance CTLT's portfolio, addin
The bioprocessing equipment company is seeing growth prospects accelerate for its non-COVID-related revenue.